Jeroen Van Goey
banner
jeroen.vangoey.be
Jeroen Van Goey
@jeroen.vangoey.be
Staff Research Engineer in BioAI at InstaDeep (part of @biontech.bsky.social)- machine learning for personalized cancer vaccines, de novo peptide sequencing and signal peptides.
From Belgium 🇧🇪 currently living in Cape Town 🇿🇦
#bioML #TeamMassSpec
Fully open source and available now, explore Winnow today:

💻 Read the blog here: bit.ly/3Lq335a

📃 See the paper: bit.ly/43go0FG

📕 Explore the codebase: bit.ly/3JLWqcM
Welcome to InstaNovo website
Discover InstaNovo, an AI-powered transformer model for de novo peptide sequencing. Boost your proteomics research with cutting-edge tool!
bit.ly
November 6, 2025 at 2:08 PM
We hope Winnow can become a standard tool to make de novo sequencing results easier to interpret. Feedback is very welcome! We’d love to hear from researchers and practitioners who might want to try Winnow in their own pipelines.
October 1, 2025 at 2:54 PM
A great collaboration with @tpjenkins.bsky.social and Konstantinos at DTU Bioengineering.
October 1, 2025 at 2:54 PM
🐍 Download the code from PyPI:
pypi.org/project/winn...
winnow-fdr
Score calibration and false discovery estimation for de novo peptide sequencing.
pypi.org
October 1, 2025 at 2:52 PM
✨ Key features of Winnow:
- DNS score calibration and rescoring
- Lightweight, non-parametric false discovery rate estimation
- Common metrics such as PEP and q-value
- Pretrained general model for zero-shot estimation with InstaNovo
- Extensible framework
October 1, 2025 at 2:51 PM
Winnow supports these discoveries by improving peptide recall while simultaneously providing accurate error estimates.
October 1, 2025 at 2:51 PM
That could mean identifying peptides that drive immune responses in diseases like cancer, tracing protein interactions in complex microbial communities, or even sequencing ancient proteins from fossil samples.
October 1, 2025 at 2:50 PM
Why does this matter? De novo sequencing tools like InstaNovo don’t just recover known biology. They can uncover what’s new and hidden.
October 1, 2025 at 2:50 PM
Over the past 9 months we developed Winnow. It provides a principled and robust method to estimate false discovery rate in de novo peptide sequencing, where the lack of reference databases makes traditional error control strategies impossible.
October 1, 2025 at 2:50 PM
A few years ago we set out to build a cutting-edge de novo peptide sequencing model. That became InstaNovo, which set a new benchmark for peptide sequencing.
bsky.app/profile/tpje...
October 1, 2025 at 2:49 PM